Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

slet amyloid toxicity: From genesis to counteracting mechanism

Full text
Author(s):
Marmentini, Carine [1] ; Branco, Renato C. S. [1] ; Boschero, Antonio C. [1] ; Kurauti, Mirian A. [2, 1]
Total Authors: 4
Affiliation:
[1] Univ Campinas UNICAMP, Lab Endocrine Pancreas & Metab, Obes & Comorbid Res Ctr OCRC, BR-13083864 Campinas, SP - Brazil
[2] State Univ Maringa UEM, Biol Sci Ctr, Dept Physiol Sci, Maringa, Parana - Brazil
Total Affiliations: 2
Document type: Review article
Source: Journal of Cellular Physiology; v. 237, n. 2 OCT 2021.
Web of Science Citations: 0
Abstract

Islet amyloid polypeptide (IAPP or amylin) is a hormone co-secreted with insulin by pancreatic beta-cells and is the major component of islet amyloid. Islet amyloid is found in the pancreas of patients with type 2 diabetes (T2D) and may be involved in beta-cell dysfunction and death, observed in this disease. Thus, investigating the aspects related to amyloid formation is relevant to the development of strategies towards beta-cell protection. In this sense, IAPP misprocessing, IAPP overproduction, and disturbances in intra- and extracellular environments seem to be decisive for IAPP to form islet amyloid. Islet amyloid toxicity in beta-cells may be triggered in intra- and/or extracellular sites by membrane damage, endoplasmic reticulum stress, autophagy disruption, mitochondrial dysfunction, inflammation, and apoptosis. Importantly, different approaches have been suggested to prevent islet amyloid cytotoxicity, from inhibition of IAPP aggregation to attenuation of cell death mechanisms. Such approaches have improved beta-cell function and prevented the development of hyperglycemia in animals. Therefore, counteracting islet amyloid may be a promising therapy for T2D treatment. (AU)

FAPESP's process: 18/24368-0 - Action of PPAR gamma (Peroxisome Proliferator Activated Receptor gamma) and AMPK (AMP-activated protein kinase) on the expression of IDE (Insulin Degrading Enzyme) in pancreatic beta cells
Grantee:Carine Marmentini
Support Opportunities: Scholarships in Brazil - Doctorate
FAPESP's process: 15/12611-0 - Molecular mechanisms involved in pancreatic beta cell disfunction and dead in diabetes mellitus: strategies for the inhibition of these processes and restoration of the insular mass
Grantee:Antonio Carlos Boschiero
Support Opportunities: Research Projects - Thematic Grants